The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection
NCT ID: NCT02065037
Last Updated: 2017-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
229 participants
INTERVENTIONAL
2014-06-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: In this study, colonoscopy using warmed carbon dioxide insufflation will be compared to standard room temperature air insufflation to see if there is a greater detection of polyps per patient.
Methods: Patients undergoing colonoscopy for screening and surveillance indications will be included and randomized to receive either room temperature room air or warmed carbon dioxide (37 degrees Celsius). Endoscopists and patients will be blinded to the intervention. Data on indication, preparation, sedation, withdrawal time will be recorded. Polyp detection rate will be the primary outcome. Secondary outcomes will include adenoma detection rate and advanced lesion detection rates.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carbon Dioxide During Screening Unsedated Colonoscopy
NCT01461564
The Use of CO2 in Routine-Colonoscopy
NCT03141697
Application of CO2 Insufflations in Colonoscopy Randomized Trial
NCT00745927
A Comparison of Methods to Detect Polyps During Colonoscopy
NCT01025960
Water Immersion and Polyp Detection: A Randomized Controlled Trial
NCT03231917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Warmed Carbon Dioxide Insufflation
warmed carbon dioxide insufflation used in colonoscopy
warmed carbon dioxide insufflation
comparator arm
Room Temperature Air Insufflation
room temperature air insufflation used in colonoscopy
room temperature air insufflation
control arm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
room temperature air insufflation
control arm
warmed carbon dioxide insufflation
comparator arm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active inflammatory bowel disease
* hereditary polyposis syndromes
* moderate to severe chronic obstructive pulmonary disease
* obstructive sleep apnea requiring continuous positive airway pressure or biphasic positive airway pressure
* neurologic diagnoses affecting ventilation
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen's University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Lawrence Hookey
Assistant Professor and Director of Endoscopy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lawrence Hookey, MD
Role: PRINCIPAL_INVESTIGATOR
Queens University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hotel Dieu Hospital
Kingston, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DMED-1658-13
Identifier Type: OTHER
Identifier Source: secondary_id
6011440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.